Applicant, as named in the Orange Book

Maia Pharms Inc

Next listed expiry: Sincalide on 20 Apr 2038. 2 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Sincalide NDA 210850 sincalide	sincalide	20 Apr 2038 patent	patent
Angiomax Rtu NDA 211215 bivalirudin	bivalirudin	20 May 2039 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	Earliest generic entry	Basis
Daptomycin NDA 217630 daptomycin	daptomycin	open now no listed protection	no listed protection
Sodium Phenylacetate And Sodium Benzoate NDA 215025 sodium benzoate; sodium phenylacetate	sodium benzoate; sodium phenylacetate	open now no listed protection	no listed protection